ATE113604T1 - Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen. - Google Patents

Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE113604T1
ATE113604T1 AT91915453T AT91915453T ATE113604T1 AT E113604 T1 ATE113604 T1 AT E113604T1 AT 91915453 T AT91915453 T AT 91915453T AT 91915453 T AT91915453 T AT 91915453T AT E113604 T1 ATE113604 T1 AT E113604T1
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical compositions
mometasone furoate
containing pharmaceutical
furoate monohydrate
Prior art date
Application number
AT91915453T
Other languages
German (de)
English (en)
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE113604(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE113604T1 publication Critical patent/ATE113604T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91915453T 1990-09-10 1991-09-06 Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen. ATE113604T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
ATE113604T1 true ATE113604T1 (de) 1994-11-15

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915453T ATE113604T1 (de) 1990-09-10 1991-09-06 Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.

Country Status (35)

Country Link
US (1) US6180781B1 (en, 2012)
EP (1) EP0548114B1 (en, 2012)
JP (1) JPH0725789B2 (en, 2012)
KR (1) KR960013445B1 (en, 2012)
CN (1) CN1030920C (en, 2012)
AT (1) ATE113604T1 (en, 2012)
AU (1) AU663471B2 (en, 2012)
BG (1) BG60755B2 (en, 2012)
CA (1) CA2091360C (en, 2012)
CZ (1) CZ281318B6 (en, 2012)
DE (2) DE19875032I2 (en, 2012)
DK (1) DK0548114T5 (en, 2012)
EE (1) EE02962B1 (en, 2012)
ES (1) ES2065701T3 (en, 2012)
FI (1) FI111078B (en, 2012)
HK (1) HK185996A (en, 2012)
HR (1) HRP920383B1 (en, 2012)
HU (1) HU213401B (en, 2012)
IE (1) IE67056B1 (en, 2012)
IL (1) IL99437A (en, 2012)
LU (1) LU90366I2 (en, 2012)
MX (2) MX9203396A (en, 2012)
MY (1) MY106644A (en, 2012)
NL (1) NL980012I2 (en, 2012)
NO (1) NO300548B1 (en, 2012)
NZ (1) NZ239711A (en, 2012)
OA (1) OA09772A (en, 2012)
PH (1) PH30443A (en, 2012)
PL (1) PL165803B1 (en, 2012)
PT (1) PT98905B (en, 2012)
SI (1) SI9111497A (en, 2012)
TW (2) TW229208B (en, 2012)
WO (1) WO1992004365A1 (en, 2012)
YU (1) YU48666B (en, 2012)
ZA (1) ZA917148B (en, 2012)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0548114T5 (da) * 1990-09-10 1995-01-30 Schering Corp Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
DE69804998T2 (de) * 1997-10-09 2002-12-12 Schering Corp., Kenilworth Mometasonfuroat-suspensionen zum zerstäuben
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
WO2008111010A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
JP5873013B2 (ja) 2009-05-29 2016-03-01 パール セラピューティクス，インコーポレイテッド ２つ以上の活性剤を呼吸器送達するための組成物、方法および系
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
MX361286B (es) 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
DK0548114T5 (da) * 1990-09-10 1995-01-30 Schering Corp Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette

Also Published As

Publication number Publication date
CA2091360C (en) 1997-04-08
LU90366I2 (fr) 1999-05-05
DE69104991D1 (de) 1994-12-08
DE19875032I2 (de) 2007-04-19
HU213401B (en) 1997-06-30
DK0548114T5 (da) 1995-01-30
HK185996A (en) 1996-10-11
NO300548B1 (no) 1997-06-16
MY106644A (en) 1995-07-31
AU8497491A (en) 1992-03-30
PT98905A (pt) 1992-09-30
TW272195B (en, 2012) 1996-03-11
YU48666B (sh) 1999-06-15
HU9300685D0 (en) 1993-06-28
CA2091360A1 (en) 1992-03-11
US6180781B1 (en) 2001-01-30
PH30443A (en) 1997-05-09
CZ281318B6 (cs) 1996-08-14
NL980012I2 (nl) 2004-11-01
JPH0725789B2 (ja) 1995-03-22
BG60755B2 (bg) 1996-02-29
MX9203396A (es) 1992-07-31
EP0548114B1 (en) 1994-11-02
NL980012I1 (nl) 1998-05-06
IE913155A1 (en) 1992-03-11
CZ38393A3 (en) 1994-01-19
KR960013445B1 (ko) 1996-10-05
FI931031A0 (fi) 1993-03-09
JPH05506667A (ja) 1993-09-30
ZA917148B (en) 1992-08-26
NO930693D0 (no) 1993-02-26
HUT64361A (en) 1993-12-28
SI9111497A (sl) 1998-04-30
EE02962B1 (et) 1997-02-17
NO930693L (no) 1993-02-26
PL165803B1 (pl) 1995-02-28
NZ239711A (en) 1992-09-25
CN1030920C (zh) 1996-02-07
WO1992004365A1 (en) 1992-03-19
MX9100990A (es) 1992-05-04
AU663471B2 (en) 1995-10-12
IL99437A0 (en) 1992-08-18
PT98905B (pt) 1998-08-31
DE69104991T2 (de) 1995-04-20
EP0548114A1 (en) 1993-06-30
FI111078B (fi) 2003-05-30
HRP920383A2 (en) 1998-06-30
HRP920383B1 (en) 2000-04-30
OA09772A (en) 1993-11-30
CN1059911A (zh) 1992-04-01
IL99437A (en) 1995-05-29
FI931031L (fi) 1993-03-09
ES2065701T3 (es) 1995-02-16
IE67056B1 (en) 1996-02-21
YU149791A (sh) 1994-01-20
TW229208B (en, 2012) 1994-09-01

Similar Documents

Publication Publication Date Title
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
SE8700499D0 (sv) Novel pharmacologically active compounds
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
ATE324T1 (de) Hydroxypropyl-triazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3483204D1 (de) 4h-3,1-benzoxazin-4-ones und verwandte verbindungen, sie enthaltende pharmazeutische zusammensetzungen und verfahren ihrer herstellung.
FI843560A7 (fi) Mevalonolaktonin analogeja ja niiden johdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia yhdistelmiä ja niide n käyttö farmaseuttisina aineina.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
FI922773A7 (fi) Uudet p-substituoidut fenyyli-4-oksibutaaniamiinijohdannaiset, menetel mä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostum ukset
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
ATE42743T1 (de) Thiochromanderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
DE69104058D1 (de) N-[(2-thenoylmerkapto-3-methyl)-butanoyl]-homocysteinthiolacton, verfahren zu seiner herstellung und diese enthaltende pharmaceutische zusammensetzungen.
ATE21893T1 (de) 2,3-dihydro-1h-indol-derivate und zwischenprodukte dafuer, verfahren zu ihrer herstellung, diese derivate enthaltende pharmazeutische zusammensetzungen und ihre herstellung.
ATE1905T1 (de) Ortho-tolyl-ester eines alpha-carboxypenizillins, verfahren zu seiner herstellung und das penizillin enthaltende pharmazeutische zusammensetzungen.
IT8421627A0 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo.
ATE1388T1 (de) Lactyl-tetrapeptid, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
RU92004492A (ru) Сульфонимидамиды, способы их получения, фармацевтическая композиция
ATE4900T1 (de) 1,2,4-triazin-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
ATE4713T1 (de) 2-oxo-benzothiazolin-, benzoxazolin- oder indolin-derivate, deren herstellung und derartige verbindungen enthaltende pharmazeutische zusammensetzungen.
ATE8622T1 (de) 3-aminopropoxyaryl-derivate, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ